Christine Chin

Radiation oncologist @NuvanceHealth. Tweets = my own.

[Christine Chin @CChinMD]

@cmwilson1113 @VCUNursing @uofunursing @UABSON @UABOBGYN @ONealCancerUAB 👏🏻

[Christine Chin @CChinMD]

Excited to be joining @GilboMd at the @NorwalkHospital @NuvanceHealth this summer.

[The Norwalk Hour @TheHourNews]

Norwalk Hospital offers tattoo-less radiation therapy for breast cancer; 'meaningful' for patients https://t.co/zG2m1xcpks

[David Kirsch, MD, PhD @DKirschMDPhD]

This is an outstanding presentation from @EileenRakovitch from @Sunnybrook on using biomarkers to optimally manage #DCIS. She has led important studies that help inform discussions between patients and #radoncs.

[Alex Melamed @headofmelon]

Nice study from Vrede et al:

The molecular subtype may not be prognostically important for low-grade endometrioid endometrial cancer

Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer https://t.co/uGKtQQS9lz via @JAMANetworkOpen part of @JAMANetwork

[ASTRO @ASTRO_org]

#ASTRO22 in the news. @ErinGillespieMD

[José Miguel Polanco ⭐️⭐️⭐️ @josepolanco10]

December 18, 2022. 34 year old Leo Messi will win the World Cup and become the greatest player of all times. Check back with me in 7 years.

[Christine Chin @CChinMD]

@AmandaRiveraMD @SylvesterCancer Congrats @AmandaRiveraMD 🤗🤗��

[ASTRO @ASTRO_org]

ASTRO In the News: Three-Week Radiation Course Effective for Early-Stage Breast Cancer. Learn more here: https://t.co/7qL3e4risf @OncologyTimes @GenesisCare

[ASTRO @ASTRO_org]

Inspiring profile of ASTRO Gold Medalist, Dr. Patricia Eifel, in @OncLive: Seeing Medicine Through the Eye of an Artist @MDAndersonNews https://t.co/KzOES6ZnNF

[Christine Chin @CChinMD]

@DrWuRadOnc 🤣🤣🤣🤣

[Sushil @Sushilberiwal]

⁦@KamravaMD⁩ leading combined effort from ⁦@AmericanBrachy⁩ ⁦@ESTRO_RT⁩ and CBG for consensus guidelines for adaptive brachytherapy for vaginal cancer ⁦@ARRO_org⁩ ⁦@ACROresident⁩ https://t.co/2oiw4Awfxq

[DrKamrava @KamravaMD]

Adjuvant Radiotherapy in Stage II Endometrial Cancer: Selective De-intensification of Adjuvant Treatment https://t.co/SBoJ2ZyBgP
Idea of "low risk" Stage II disease is evolving
Diff definitions (PMID 29885996, 31200993 )
Diff treat strategies (VC, mini pelvis)

[Christine Chin @CChinMD]

Such a great line up at speakers at this year’s Annual @NYRS_RFS meeting, rad onc section! @DHorowitzMD @RadOnc_MD @DrBPres @LiorBraunstein, Michael Chuong, Erik Sulman and Steven Frank! 🙌🏼

[Christine Chin @CChinMD]

@AtTheBeam @ClaireBanielMD @ColumbiaRadOnc @StanfordRO_Res Aww love what you are doing… everyone looks so happy! 😃

[At The Beam Podcast @AtTheBeam]

A new episode is now out on endometrial cancer featuring @ClaireBanielMD! Huge thanks to @CChinMD for her review of this episode! You can find it on iTunes, Spotify (linked below), or your preferred podcast app! #endometrialcancer #radonc @ColumbiaRadOnc @StanfordRO_Res

[Christine Chin @CChinMD]

@ingridisa 😂😂👍🏻👍🏻 good job!!!

[American Brachy @AmericanBrachy]

Review of a Discipline with a Forward Focus Symposium will provide brachy nurses, clinicians & physicists with an opportunity to present and learn about the vital role of nursing in brachy treatments.https://t.co/pVViBvigFJ #BrachyNurse #brachytherapynurses #ThisIsBrachytherapy

[Connor Kinslow, MD @RadOncConnor]

I'm very flattered that @GoHealio @HemOncToday was interested in interviewing my very talented co-resident, Matt Garrett, and I on our experience in the Opera before medical school.
Thanks to @ColumbiaRadOnc and @MetOpera

https://t.co/hvwFxQsIro

[Timothy Kerwin, MD @KerwinXRT]

I agree with @jamesbyu that the proposed RO-APM is poorly designed and would not be an improvement over flawed predecessors (the OCM or the SGR). Time for CMS to discontinue disproportionate reimbursement reductions in radiation oncology @IJROBP #radonc https://t.co/ytRcveEfgC

[Nat Lester-Coll, MD @DrLesterColl]

🚨@OncoAlert In this RCT of 378 pts tx’d w adjuvant breast radiotherapy, tx in the prone position was statistically significantly associated with lower rates of moist desquamation (26.9%) vs treatment in the standard supine position (39.6%) #bcsm #radonc

https://t.co/aen3Mp9yMS